X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-12 | TERN | Lu Hongbo | Dir | P - Purchase | $10.50 | +476,190 | 476,190 | New | +$4,999,995 | ||||||
| D | 2024-09-10 | TERN | Vignola Mark J. | CFO | S - Sale+OE | $11.00 | -10,000 | 91,940 | -10% | -$110,000 | |||||
| D | 2024-09-09 | TERN | Quigley Jill M. | Dir | S - Sale+OE | $10.00 | -17,235 | 15,000 | -53% | -$172,350 | |||||
| M | 2024-08-01 | TERN | Quigley Jill M. | Dir | S - Sale | $7.57 | -15,000 | 15,000 | -50% | -$113,580 | |||||
| M | 2024-07-15 | TERN | Gordon Carl L | Dir, 10% | S - Sale | $10.00 | -56,164 | 755,635 | -7% | -$561,640 | |||||
| M | 2024-07-15 | TERN | Orbimed Advisors LLC | Dir, 10% | S - Sale | $10.00 | -56,164 | 755,635 | -7% | -$561,640 | |||||
| DM | 2024-07-15 | TERN | Quigley Jill M. | Dir | S - Sale+OE | $10.00 | -14,765 | 30,000 | -33% | -$147,660 | |||||
2024-05-31 | TERN | Yoon Seokho Bryan | COO, GC | P - Purchase | $4.44 | +4,791 | 91,940 | +5% | +$21,272 | ||||||
2024-05-31 | TERN | Vignola Mark J. | CFO | P - Purchase | $4.44 | +4,791 | 91,940 | +5% | +$21,272 | ||||||
| M | 2024-04-01 | TERN | Vivo Opportunity, LLC | 10% | S - Sale | $6.65 | -420,663 | 6,237,329 | -6% | -$2,796,859 | |||||
2023-11-30 | TERN | Yoon Seokho Bryan | COO, GC | P - Purchase | $3.78 | +743 | 18,399 | +4% | +$2,809 | ||||||
2023-11-30 | TERN | Vignola Mark J. | CFO | P - Purchase | $3.78 | +743 | 18,399 | +4% | +$2,809 | ||||||
2023-05-31 | TERN | Vignola Mark J. | CFO | P - Purchase | $1.41 | +9,997 | 17,656 | +131% | +$14,096 | ||||||
2023-05-31 | TERN | Yoon Seokho Bryan | COO, GC | P - Purchase | $1.41 | +9,997 | 17,656 | +131% | +$14,096 | ||||||
2023-05-31 | TERN | Sundaram Senthil Vel | CEO | P - Purchase | $1.41 | +2,111 | 9,770 | +28% | +$2,977 | ||||||
| D | 2022-11-30 | TERN | Yoon Seokho Bryan | COO, GC | P - Purchase | $1.41 | +3 | 7,659 | 0% | +$4 | |||||
| D | 2022-11-30 | TERN | Vignola Mark J. | CFO | P - Purchase | $1.41 | +3 | 7,659 | 0% | +$4 | |||||
| D | 2022-11-30 | TERN | Sundaram Senthil Vel | CEO | P - Purchase | $1.41 | +3 | 7,659 | 0% | +$4 | |||||
2022-12-23 | TERN | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $7.25 | +137,931 | 7,619,135 | +2% | +$1,000,000 | ||||||
2022-12-23 | TERN | Gordon Carl L | Dir, 10% | P - Purchase | $7.25 | +137,931 | 7,619,135 | +2% | +$1,000,000 | ||||||
2022-12-23 | TERN | Vivo Opportunity, LLC | 10% | P - Purchase | $7.25 | +758,620 | 6,657,992 | +13% | +$5,499,995 | ||||||
2022-12-23 | TERN | Lu Hongbo | Dir | P - Purchase | $7.25 | +758,620 | 4,340,212 | +21% | +$5,499,995 | ||||||
2022-11-23 | TERN | Lav Biosciences Fund V, L.P. | 10% | S - Sale | $5.50 | -1,500,000 | 1,816,460 | -45% | -$8,250,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |